TN2010000610A1 - Calcium ion channel modulators & uses thereof - Google Patents

Calcium ion channel modulators & uses thereof

Info

Publication number
TN2010000610A1
TN2010000610A1 TNP2010000610A TN2010000610A TN2010000610A1 TN 2010000610 A1 TN2010000610 A1 TN 2010000610A1 TN P2010000610 A TNP2010000610 A TN P2010000610A TN 2010000610 A TN2010000610 A TN 2010000610A TN 2010000610 A1 TN2010000610 A1 TN 2010000610A1
Authority
TN
Tunisia
Prior art keywords
hydrogen
alkyl
halogen
dialkylamino
nitro
Prior art date
Application number
TNP2010000610A
Other languages
French (fr)
Inventor
Nawaz Mohamed Khan
Svenja Burckhardt
Julie Elaine Cansfield
Ngoc Tri Vo
Richard Edward Armer
Raymond John Boffey
Original Assignee
Lectus Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2009/050787 external-priority patent/WO2010001179A2/en
Application filed by Lectus Therapeutics Ltd filed Critical Lectus Therapeutics Ltd
Publication of TN2010000610A1 publication Critical patent/TN2010000610A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of formula (1), salts and pro-drugs wherein : R1,R2 ,R3 and R4 are hydrogen, alkyl, hydroxyalkyl, halogen, haloalkyl, alkoxy, haloalkoxy, alkoxycarbonyl, carboxyl, hydroxyl, nitro, amino, monalkylamino,dialkylamino, acylamino, amkoxycarbonylamino, alkylsulphonyl, arylsulphonyl, alkylsulphonylamino, arylsulphonylamino, aminosulphonyl or cyano, or any two of R1 to R4 that are adjacent on the ring may together represent the moiety -O-(CH2)n -O- wherein n is 1 to 3 ; R5 is hydrogen or alkyl; R6 is hydrogen or alkyl ; and X is selected from the group consisting of : (a) groups of formula OR7 wherein R7 is hydrogen or alkyl which is optionally substituted with a substituent selected from alkylsulphonylalkyl, saturated or partially unsaturated heterocyclic, alkoxy, carboxyl, nitro, amino, monalkylamino, dialkylamino, halogen, and alkoxycarbonyl, provided that when R7 is hydrogen or ethyl, then R1, R2, R3 and R4 cannot be selected from hydrogen, halogen and alkyl; and (b) groups of formula NR8R9 wherein R8 and R9 together with the nitrogen atom to which they are attached form a saturated or partially unsaturated heterocyclic group which optionally contains at least one more heteroatom selected from nitrogen, oxygen and sulphur atoms, said saturated or partially unsaturated heterocyclic group optionally further being substituted by one or more substituents selected from alkyl, halogen, haloalkyl, alkoxy, alkoxycarbonyl, carboxyl, nitro, amino, monalkylamino, dialkylamino and hydroxyl, privided that: (i) when R8+R9+N = piperazine , and >= 1 of R1 to R4 are hydrogen, hydroxyl, nitro, amino, alkyllamino, dialkylamino, alkoxycarbonylamino, halogen, alkoxy or alkyl, the nitrogen atom at the 4-position of the piperazine is not alkyl substituted, (ii) when each of R1, R2, R3,R4 ,R5 and R6 is hydrogen, X is not unsubstituted piperazinyl or unsubstituted morpholino, (iii) when each of R1, R2 ,R4 ,R5 and R6 is hydrogen and R3 hydrogen, bromine or hydroxyl, X is not methoxy, (iv) when each of R2 and R3 is methoxy or they together represent -0-CH2-O- and each of R1, R4, R5 and R6 is hydrogen, X is not unsubstituted piperidine, are Cavx channel blockers and are of use in the treatment of various conditions including pain.
TNP2010000610A 2009-07-03 2010-12-27 Calcium ion channel modulators & uses thereof TN2010000610A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2009/050787 WO2010001179A2 (en) 2008-07-03 2009-07-03 Calcium ion channel modulators & uses thereof

Publications (1)

Publication Number Publication Date
TN2010000610A1 true TN2010000610A1 (en) 2012-05-24

Family

ID=55024682

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000610A TN2010000610A1 (en) 2009-07-03 2010-12-27 Calcium ion channel modulators & uses thereof

Country Status (1)

Country Link
TN (1) TN2010000610A1 (en)

Similar Documents

Publication Publication Date Title
DOP2010000183A (en) ITAZOL DERIVATIVES USED AS PI 3-CINASA INHIBITORS
AR061806A1 (en) DERIVATIVES OF ALQUILPIRIDAZINA AS INHIBITORS OF 11B-HSD1 (T2D)
MY153910A (en) BICYCLIC y-AMINO ACID DERIVATIVE
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
PA8791801A1 (en) PIRAZOL COMPOUNDS
RS52261B (en) Amidophenoxyindazoles useful as inhibitors of c-met
BRPI0720993B8 (en) uses of cyclopamine analog compounds
RS54260B1 (en) Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
EA201101098A1 (en) COMBINATIONS CONTAINING METOTREXAT AND INHIBITORS DGND
CR11518A (en) CARBAMOIL COMPOUNDS AS DGAT1 190 INHIBITORS
BRPI0511433A (en) substituted quinoline derivatives as mitotic kinesin inhibitors
CO6261379A2 (en) CYCLOPENTANDIONA COMPOUNDS AND USEFUL DERIVATIVES AS HERBICIDES
ECSP11010830A (en) HETEROARILO DERIVATIVES AS DGAT1 INHIBITORS
MX2009003256A (en) Stat3/5 activation inhibitor.
NO20083408L (en) Corrosion inhibitors that have increased biodegradability and reduced toxicity
MY159910A (en) Pyrrolidin-2-one derivatives as androgen receptor modulator
AR068538A1 (en) 5-MEMBER HETEROCICLIC COMPOUND WITH SUPPRESSING ACTIVITY OF THE ACID SECRETION
EA200900924A1 (en) CYCLIZED DERIVATIVES AS EG-5 INHIBITORS
CR11220A (en) PIRIMIDINE DERIVATIVES 934
AR060812A1 (en) MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MGLUR5, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN PATOPHYSIOLOGICAL PROCESSES AND DISORDERS AFFECTING THE SCN
EA201170093A1 (en) SUBSTITUTED N-OXYDPYRAZINE DERIVATIVES
ECSP088805A (en) 2- (PIRIDIN-2-IL) -PIRIMIDINAS AS FUNGICIDES
CY1116391T1 (en) ETHINYLIC PRODUCERS AS MGLUR5 POSITIVE ALLOY REGULATORS
BRPI0517622A (en) unsubstituted imides as polymerization initiators
CO6551705A2 (en) DERIVATIVES OF 3.4.4A.10B- TETRAHIDRO-1H-TIOPIRANO- [4.3-C] - ISOQUINOLINA